Assignee
SYNLOGIC OPERATING CO INC
22 granted patents·32 pending applications·71 citations·filing 2016–2024
Top patents by PatentIndex Score
54 records- 0196US10273489B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 30, 2019·12 cites·6 claims
- 0294US11291693B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 5, 2022·9 cites·19 claims
- 0394US10933102B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2017·Granted Mar 2, 2021·7 cites·22 claims
- 0494US10610546B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 7, 2020·7 cites·8 claims
- 0593US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 0692US11060073B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2017·Granted Jul 13, 2021·5 cites·38 claims
- 0791US11723932B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2017·Granted Aug 15, 2023·5 cites·7 claims
- 0890US11766463B2Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2022·Granted Sep 26, 2023·3 cites·8 claims
- 0990US11618894B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 4, 2023·5 cites·33 claims
- 1089US10195234B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Feb 5, 2019·6 cites·15 claims
- 1188US12171790B2Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2023·Granted Dec 24, 2024·1 cites·29 claims
- 1285US11879123B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2018·Granted Jan 23, 2024·4 cites·24 claims
- 1376US12545886B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2023·Granted Feb 10, 2026·0 cites·20 claims
- 1475US2025295707A1Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2024·Application pending·0 cites
- 1574US2024382536A1Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 1673US11845964B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Dec 19, 2023·0 cites·20 claims
- 1773US2024076645A1Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 1872US12409195B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Sep 9, 2025·0 cites·9 claims
- 1972US2021095297A1Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal BarrierSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 2071US11896627B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2022·Granted Feb 13, 2024·0 cites·22 claims
- 2169US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2267US11859189B2Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2022·Granted Jan 2, 2024·0 cites·14 claims
- 2367US2024110192A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2466US11883439B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2020·Granted Jan 30, 2024·0 cites·17 claims
- 2566US2024102024A1Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2665US11384359B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jul 12, 2022·0 cites·18 claims
- 2764US2024180974A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2862US2022233609A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2961US2024110191A1Engineered microorganismsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3060US2023174926A1Bacteria engineered to treat disorders involving the catabolism of leucineSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3159US2023332164A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3258US2023293603A1Recombinant bacteria for production of d-lactate and/or l-lactate and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3357US2024191176A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3457US2021369836A1Surface display of proteins on recombinant bacteria and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3556US2024197843A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3656US2022257732A1Enumeration of genetically engineered microorganisms by live cell counting techniquesSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 3756US2022168362A1Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acidSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 3856US2023043588A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3955US2023183295A1Recombinant bacteria for use as a vaccine to prevent covid19 infectionSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4054US11685925B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jun 27, 2023·0 cites·17 claims
- 4154US2024316122A1Methods of treating cancer using recombinant microorganisms expressing a sting agonistSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 4253US2021130806A1Engineered bacteria expressing racemase for treating diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
- 4353US2024316121A1Microorganisms engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4451US11273184B2Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2016·Granted Mar 15, 2022·0 cites·20 claims
- 4551US2022362311A1Optimized bacteria engineered to treat disorders involving the catabolism of leucine, isoleucine, and/or valineSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 4651US2023092431A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4748US2023172997A1Recombinant bacteria for production of indole-3-acetic acid (iaa) and uses thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4846US11439673B2Bacteria engineered to treat liver diseaseSYNLOGIC OPERATING CO INC·Filed 2019·Granted Sep 13, 2022·0 cites·22 claims
- 4946US2023105474A1Recombinant bacteria engineered to treat diseases associated with uric acid and methods of use thereofSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 5045US2020149053A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SYNLOGIC OPERATING CO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →